USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$5.85B
Market Cap
30.85
P/E Ratio
4.29
EPS
$236.81
52 Week High
$108.60
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.7B |
| Total Revenue | $3B |
| Cost Of Revenue | $1.3B |
| Costof Goods And Services Sold | $1.3B |
| Operating Income | $151M |
| Selling General And Administrative | $995M |
| Research And Development | $162M |
| Operating Expenses | $1.6B |
| Investment Income Net | - |
| Net Interest Income | -$76M |
| Interest Income | $8M |
| Interest Expense | $84M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $275M |
| Income Before Tax | $75M |
| Income Tax Expense | $5.3M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $70M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $178M |
| Ebitda | $453M |
| Net Income | $70M |
| Field | Value (USD) |
|---|---|
| Total Assets | $7.1B |
| Total Current Assets | $1.5B |
| Cash And Cash Equivalents At Carrying Value | $290M |
| Cash And Short Term Investments | $290M |
| Inventory | $600M |
| Current Net Receivables | $459M |
| Total Non Current Assets | $5.6B |
| Property Plant Equipment | $612M |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $2.3B |
| Intangible Assets Excluding Goodwill | $2.3B |
| Goodwill | $2.6B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $121M |
| Other Non Current Assets | - |
| Total Liabilities | $2.8B |
| Total Current Liabilities | $649M |
| Current Accounts Payable | $141M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $100M |
| Total Non Current Liabilities | $2.2B |
| Capital Lease Obligations | $99M |
| Long Term Debt | $1.6B |
| Current Long Term Debt | $100M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1.8B |
| Other Current Liabilities | $367M |
| Other Non Current Liabilities | $104M |
| Total Shareholder Equity | $4.3B |
| Treasury Stock | - |
| Retained Earnings | $4.1B |
| Common Stock | $48M |
| Common Stock Shares Outstanding | $47M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $636M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $275M |
| Capital Expenditures | $126M |
| Change In Receivables | - |
| Change In Inventory | $1.7M |
| Profit Loss | - |
| Cashflow From Investment | -$99M |
| Cashflow From Financing | -$422M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $64M |
| Dividend Payout Common Stock | $64M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$200M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $70M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.7B |
| Total Revenue | $3B |
| Cost Of Revenue | $1.3B |
| Costof Goods And Services Sold | $1.3B |
| Operating Income | $151M |
| Selling General And Administrative | $995M |
| Research And Development | $162M |
| Operating Expenses | $1.6B |
| Investment Income Net | - |
| Net Interest Income | -$76M |
| Interest Income | $8M |
| Interest Expense | $84M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $275M |
| Income Before Tax | $75M |
| Income Tax Expense | $5.3M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $70M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $178M |
| Ebitda | $453M |
| Net Income | $70M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-08-15 |
| Declaration Date | 2025-07-31 |
| Record Date | 2025-08-15 |
| Payment Date | 2025-09-15 |
| Amount | 0.34 |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Teleflex Incorporated (TFX), based in Wayne, Pennsylvania, is a leading global provider of innovative medical devices that cater to the critical care and surgical markets. With a focus on advancing and enhancing patient care, Teleflex develops a diverse portfolio of specialty products designed to improve safety and efficacy across various medical procedures. The company's commitment to innovation and quality has positioned it as a trusted partner in healthcare, serving clinicians and patients worldwide.